The phase 3b BATURA study showed Airsupra (albuterol/budesonide) achieved a statistically significant reduction in the risk of severe asthma exacerbations when used as needed for rescue therapy ...
The week has started with reports that activist investor Starboard Value has amassed a $1 billion stake in pharma group ...
The reporting week has started with reports that activist investor Starboard Value has amassed a $1 billion stake in pharma ...